Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05954585 · ClinicalTrials.gov registry record · NA
Family Navigator Intervention
A NA study, sponsored by Rhode Island Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 54
- Enrollment target
NCT05954585: Clinical Trial NA study, sponsored by Rhode Island Hospital.
NCT05954585 is a NA study that was terminated before completion, run by Rhode Island Hospital. The registered enrollment target is 54 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05954585, a NA study, was terminated before completion, sponsored by Rhode Island Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
Study Summary
This study will develop and examine the feasibility and acceptability of a family navigator protocol while leveraging digital health communication. It will employ an ecological model within a socio-cultural theoretic framework of mental health service disparities and barriers to treatment.
Primary Outcome
adapted CASA
Interventions
- BEHAVIORAL Treatment as usual
- BEHAVIORAL Family Navigator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2023-12-02 |
| Est. Completion | 2024-05-31 |
| Phase | NA |
Why NCT05954585 stopped before completion
NCT05954585 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Treatment as usual is the first listed.
NCT05954585 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05954585 about?
NCT05954585 is a clinical study titled "Family Navigator Intervention". This study will develop and examine the feasibility and acceptability of a family navigator protocol while leveraging digital health communication. It will employ an ecological model within a socio-cultural theoretic framework of mental health service disparities and barriers to treatment.
What is the current status of trial NCT05954585?
This trial is currently terminated. It is a NA study. The enrollment target is 54 participants. The study started on 2023-12-02. Estimated completion is 2024-05-31.
What interventions are being tested in trial NCT05954585?
The interventions under investigation include: Treatment as usual (BEHAVIORAL), Family Navigator (BEHAVIORAL).
Who is sponsoring clinical trial NCT05954585?
This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05954585's enrollment target sits among peer trials
54 1268th of 2000 higher than 730 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI